Company Overview
About PhaseV
PhaseV is an AI clinical trial platform that uses predictive analytics to optimize trial design, site selection, patient enrollment, and protocol adherence — delivering dramatic efficiency improvements over traditional trial execution. The company raised $50 million in Series A financing in May 2025 co-led by Accel and Insight Partners, and entered 2026 with 40+ global pharmaceutical sponsors as customers including 7 of the world's top pharmaceutical companies.
Business Model & Competitive Advantage
The platform's reported outcomes are compelling: 50% reduction in trial costs, 40% reduction in enrollment size required, and 40% reduction in trial duration. For a pharmaceutical company running a Phase 3 trial that would otherwise cost $500 million and take 5 years, these improvements represent $250 million in savings and 2 years of development time — potentially worth $2-3 billion in earlier market exclusivity.
Competitive Landscape 2025–2026
In 2026, the company reports that biopharma is shifting from AI pilot programs to full-scale execution — adoption is moving from innovation teams to core clinical operations. This inflection from piloting to procurement represents the kind of enterprise buying pattern that precedes accelerated revenue growth. PhaseV's proprietary datasets from completed trials create a compounding data advantage that improves its predictive models with each additional trial.
Open Positions
Reddit Discussions
Key Differentiators
Emerging Innovator
PhaseV is an emerging player bringing innovative solutions to the BioTech market.
Frequently Asked Questions
Not So Random Others
a2z Radiology AI
a2z Radiology AI has developed a whole-body CT analysis platform that simultaneously screens for over 24 medical conditions across a single CT scan, including incidental cancers, coronary artery disea
Adept AI
Adept AI was founded in 2022 by a team of former OpenAI, DeepMind, and Google Brain researchers to build AI that can take actions on computers — navigating software interfaces, filling forms, and exec
Duckie
Duckie is a San Francisco-based AI customer support platform — backed by Y Combinator (W24) with $500,000 in funding from Y Combinator, Andreessen Horowitz, Greylock, KungHo Fund, Netflix, and 5 addit
Plenty
Plenty is a San Francisco-based indoor vertical farming company that uses AI, machine learning, and robotics to grow leafy greens and other produce in controlled indoor environments. The company has r
Oura
Oura is the maker of the Oura Ring, a premium smart ring that tracks sleep, recovery, readiness, and health metrics through continuous biometric sensing. The company raised $900 million in Series E fi
Nira Energy
Nira Energy is a Denver-based renewable energy software company providing grid capacity mapping and interconnection analysis tools that help solar, battery storage, and data center developers identify
Compare PhaseV with Competitors
Side-by-side AI visibility scores, platform breakdown, and market position.
Claim This Profile
Are you from PhaseV? Claim your profile to see full AI mention excerpts, get weekly visibility change alerts, and optimize how AI systems describe your brand.
Claim PhaseV Profile →Track AI Visibility in Real Time
Monitor how ChatGPT, Gemini, Perplexity, and Claude mention PhaseV vs competitors. Get alerts when AI recommendations shift.
Start Free Tracking →